Matricellular proteins: new molecular targets to prevent heart failure.
about
Tenascin-C in development and disease of blood vesselsOsteopontin deficiency aggravates hepatic injury induced by ischemia-reperfusion in miceMatricellular proteins and biomaterials.Transcriptional profiling of left ventricle and peripheral blood mononuclear cells in a rat model of postinfarction heart failure.Association of serum periostin with cardiac function and short-term prognosis in acute myocardial infarction patientsEplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trialMatricellular proteins in cardiac adaptation and disease.Osteopontin is an endogenous modulator of the constitutively activated phenotype of pulmonary adventitial fibroblasts in hypoxic pulmonary hypertension.Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localizationAcetaminophen attenuates doxorubicin-induced cardiac fibrosis via osteopontin and GATA4 regulation: reduction of oxidant levels.Significance of myocardial tenascin-C expression in left ventricular remodelling and long-term outcome in patients with dilated cardiomyopathyIntegrating the myocardial matrix into heart failure recognition and management.Tenascin-C and mechanotransduction in the development and diseases of cardiovascular systemTargeting osteopontin, the silent partner of Na+/H+ exchanger isoform 1 in cardiac remodeling.Osteopontin is proteolytically processed by matrix metalloproteinase 9.Molecular profiling of dilated cardiomyopathy that progresses to heart failure.Cardiac fibroblast-derived extracellular matrix (biomatrix) as a model for the studies of cardiac primitive cell biological properties in normal and pathological adult human heart.Inhibition of coagulation factor Xa improves myocardial function during CVB3-induced myocarditis.Atorvastatin Improves Ventricular Remodeling after Myocardial Infarction by Interfering with Collagen Metabolism.Dysregulation of matricellular proteins is an early signature of pathology in laminin-deficient muscular dystrophy.Melusin protects from cardiac rupture and improves functional remodelling after myocardial infarction.Aquaporin 4-dependent expression of glial fibrillary acidic protein and tenascin-C in activated astrocytes in stab wound mouse brain and in primary culture.Osteopontin and galectin-3 predict the risk of ventricular tachycardia and fibrillation in heart failure patients with implantable defibrillators.Tenascin-C Is a Major Component of the Fibrogenic Niche in Kidney Fibrosis.
P2860
Q27027610-2CA92144-C562-4008-A299-B94E59D6FB36Q33720224-A634B365-9A27-4E7F-BFE9-B7C6E7311B0AQ34040283-82D7D3D9-F93F-43FB-9FA8-580950374C8BQ34481362-E57EC3E2-EFFE-4C62-89E3-534330DBB5A2Q35106256-66ADCC24-6754-4729-871A-348324E740DFQ35181260-B13EFCD3-D525-4727-8218-C265259FBEC3Q35542423-69D1FD68-6579-4041-AFD3-436F480A3C70Q36185483-A7547464-8D6A-443E-A3E5-6AC7E0FA757DQ36578825-4E17AFB5-B27F-4A09-84A8-4DB163D2B078Q37086060-E8559067-0654-44CF-B06A-4E60019D7E84Q37344043-73E76E9A-A65E-4D1A-A6A7-579085E91E11Q37406111-185B91B6-E233-4A52-913C-7623C1F25ED7Q38239651-B0B8347C-A465-499E-8F8F-464F5E75E84CQ38354012-F5C46CA6-4D18-4D30-9A24-88BD95248E6EQ38608860-01247155-BBA5-4256-80D8-26A256A193A7Q39726366-7698430E-5F43-4D30-AF0F-22229BAD215CQ40880502-BB45F832-AA08-43AF-8237-17F9F720F1C8Q42236619-DD61AD2F-2493-4D39-BD8D-2979B272D9D5Q42364213-B4F419E4-1332-4E8B-81CE-ADB295295791Q42754638-B31E2590-A369-4675-AA22-57253DE8925EQ46076454-562F0F7A-A39B-4E9D-860C-DFBD1308C0A2Q48573347-1AF233A9-D63A-4913-885A-F9866063134BQ48898746-774C658E-7D78-4980-B5F1-51DAB0D106C3Q51524514-BDEBB9B5-AACB-4620-82E5-6C010E6CECED
P2860
Matricellular proteins: new molecular targets to prevent heart failure.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Matricellular proteins: new molecular targets to prevent heart failure.
@en
Matricellular proteins: new molecular targets to prevent heart failure.
@nl
type
label
Matricellular proteins: new molecular targets to prevent heart failure.
@en
Matricellular proteins: new molecular targets to prevent heart failure.
@nl
prefLabel
Matricellular proteins: new molecular targets to prevent heart failure.
@en
Matricellular proteins: new molecular targets to prevent heart failure.
@nl
P2860
P1476
Matricellular proteins: new molecular targets to prevent heart failure.
@en
P2093
Hiroshi Okamoto
Kyoko Imanaka-Yoshida
P2860
P304
P356
10.1111/J.1755-5922.2011.00276.X
P577
2011-08-04T00:00:00Z